Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) FCF Margin (2016 - 2025)

Historic FCF Margin for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to 12.83%.

  • Bristol Myers Squibb's FCF Margin fell 200700.0% to 12.83% in Q4 2025 from the same period last year, while for Dec 2025 it was 26.65%, marking a year-over-year decrease of 22100.0%. This contributed to the annual value of 26.65% for FY2025, which is 22100.0% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's FCF Margin is 12.83%, which was down 200700.0% from 49.02% recorded in Q3 2025.
  • Bristol Myers Squibb's FCF Margin's 5-year high stood at 49.02% during Q3 2025, with a 5-year trough of 12.83% in Q4 2025.
  • Moreover, its 5-year median value for FCF Margin was 29.77% (2022), whereas its average is 28.48%.
  • As far as peak fluctuations go, Bristol Myers Squibb's FCF Margin soared by 229200bps in 2021, and later plummeted by -200700bps in 2025.
  • Over the past 5 years, Bristol Myers Squibb's FCF Margin (Quarter) stood at 31.18% in 2021, then dropped by -17bps to 25.95% in 2022, then soared by 32bps to 34.17% in 2023, then fell by -4bps to 32.9% in 2024, then plummeted by -61bps to 12.83% in 2025.
  • Its FCF Margin stands at 12.83% for Q4 2025, versus 49.02% for Q3 2025 and 28.98% for Q2 2025.